These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9573573)

  • 61. [Hepatorenal syndrome].
    Baccaro ME; Guevara M
    Gastroenterol Hepatol; 2007 Nov; 30(9):548-54. PubMed ID: 17980134
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.
    Arroyo V; Colmenero J
    J Hepatol; 2003; 38 Suppl 1():S69-89. PubMed ID: 12591187
    [No Abstract]   [Full Text] [Related]  

  • 63. Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials.
    Mookerjee RP; Jalan R
    Crit Care; 2008; 12(2):119. PubMed ID: 18394181
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medical management of hepatorenal syndrome.
    Davenport A; Ahmad J; Al-Khafaji A; Kellum JA; Genyk YS; Nadim MK
    Nephrol Dial Transplant; 2012 Jan; 27(1):34-41. PubMed ID: 22287700
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of ascites in patients with chronic liver disease.
    Aiza I; Perez GO; Schiff ER
    Am J Gastroenterol; 1994 Nov; 89(11):1949-56. PubMed ID: 7942716
    [No Abstract]   [Full Text] [Related]  

  • 66. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatorenal syndrome and ascites--questions and answers.
    Bernardi M; Blendis L; Burroughs AK; Laffi G; Rodes J; Gentilini P
    Liver; 1999; 19(1 Suppl):15-74. PubMed ID: 10227000
    [No Abstract]   [Full Text] [Related]  

  • 68. [Renal insufficiency in liver transplantation].
    Rimola A
    Nefrologia; 2002; 22 Suppl 5():69-71. PubMed ID: 12107922
    [No Abstract]   [Full Text] [Related]  

  • 69. [Hepatorenal syndrome].
    Romejko-Ciepielewska K; Niemczyk S
    Pol Arch Med Wewn; 2005 Aug; 114(2):813-8. PubMed ID: 16808322
    [No Abstract]   [Full Text] [Related]  

  • 70. [Hepatorenal syndrome].
    Kürer I; Sommerer A; Puhl G; Kaisers U; Boemke W
    Anaesthesist; 2006 Jan; 55(1):95-107; quiz 108-9. PubMed ID: 16372167
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Hepatorenal syndrome: incidence, predictive factors and prognosis].
    Moreau R
    Gastroenterol Clin Biol; 1994; 18(5):541-3. PubMed ID: 7813880
    [No Abstract]   [Full Text] [Related]  

  • 72. The hepatorenal syndrome.
    Munoz SJ
    Med Clin North Am; 2008 Jul; 92(4):813-37, viii-ix. PubMed ID: 18570944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatorenal syndrome: emerging perspectives.
    Epstein M
    Semin Nephrol; 1997 Nov; 17(6):563-75. PubMed ID: 9353866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatorenal disorders: role of the sympathetic nervous system.
    Henriksen JH; Ring-Larsen H
    Semin Liver Dis; 1994 Feb; 14(1):35-43. PubMed ID: 8016660
    [No Abstract]   [Full Text] [Related]  

  • 75. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A; Ginès P
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment.
    Ginès P; Fernández-Esparrach G; Arroyo V
    Baillieres Clin Gastroenterol; 1997 Jun; 11(2):365-85. PubMed ID: 9395753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites.
    Sersté T; Lebrec D; Valla D; Moreau R
    Acta Gastroenterol Belg; 2008; 71(1):9-14. PubMed ID: 18396743
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
    Bertino G; Privitera G; Purrello F; Demma S; Crisafulli E; Spadaro L; Koukias N; Tsochatzis EA
    Intern Emerg Med; 2016 Oct; 11(7):905-16. PubMed ID: 27273018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.